Generated by GPT-5-mini| Cannabis sativa | |
|---|---|
![]() Thayne Tuason · CC BY-SA 4.0 · source | |
| Name | Cannabis sativa |
| Genus | Cannabis |
| Species | sativa |
| Authority | L. |
Cannabis sativa is a flowering plant in the family Cannabaceae widely cultivated and referenced across agriculture, medicine, law, and culture. It appears in botanical works by Carl Linnaeus, agricultural reports from United States Department of Agriculture, ethnobotanical surveys associated with British Museum collections, and policy debates in forums like United Nations assemblies and World Health Organization panels.
Plants classified as Cannabis sativa are described in taxonomic treatments by Carl Linnaeus, Jean-Baptiste Lamarck, and modern monographs from institutions such as the Royal Botanic Gardens, Kew and the Smithsonian Institution. Morphological descriptions compare sativa forms with other taxa in the genus cited in studies published by Royal Society journals and compilations at Harvard University Herbaria. Diagnostic characters—leaf shape, palmate leaves, dioecious flowers, and indumentum—are discussed alongside type specimens held at the Linnean Society of London and referenced in floras like those of the Flora of China, the Flora Europaea, and the Gray Herbarium Index.
Reports of naturalized and cultivated populations occur across continents in publications from the United States Geological Survey, the European Environment Agency, and the Food and Agriculture Organization of the United Nations. Historical dispersal routes are reconstructed using records from the Silk Road, accounts by Marco Polo, and colonial-era botanical exchanges linked to the Dutch East India Company and the British East India Company. Present-day habitats include temperate arable lands cataloged by the International Union for Conservation of Nature and disturbed sites documented in surveys by the Royal Botanic Garden Edinburgh and the Botanical Society of Britain and Ireland.
Cultivation methods for fiber, seed, and cannabinoid production are detailed in manuals used by Food and Agriculture Organization of the United Nations programs, agricultural extension services like those of Iowa State University, and industry guides from groups such as the Hemp Industries Association. Traditional uses appear in ethnographies from the National Museum of Anthropology (Mexico), texts by Herodotus, and pharmacopoeias held by the Uppsala University Library. Industrial applications—textiles, paper, biocomposites—are compared in reports from European Commission research projects, engineering studies at the Massachusetts Institute of Technology, and lifecycle analyses by the International Energy Agency.
Phytochemical profiles are reported in journals associated with the American Chemical Society, the Royal Society of Chemistry, and research institutes like Johns Hopkins University School of Medicine. Major metabolites such as tetrahydrocannabinol and cannabidiol are characterized in pharmacology reviews cited at National Institutes of Health and discussed in clinical trial registries overseen by the European Medicines Agency and the U.S. Food and Drug Administration. Receptor interactions are contextualized with foundational work on the endocannabinoid system by researchers linked to University of Cambridge, McMaster University, and University of California, San Francisco.
Evidence summaries on therapeutic uses and risks appear in assessments by the World Health Organization, systematic reviews published in journals of the Cochrane Collaboration, and guidelines from national bodies such as Public Health England and the Centers for Disease Control and Prevention. Acute and chronic effects are addressed in clinical studies conducted at hospitals affiliated with Massachusetts General Hospital, Mount Sinai Hospital (New York City), and research centers like the New York State Psychiatric Institute. Safety considerations in occupational settings and product standards are developed by agencies such as the Occupational Safety and Health Administration and the European Food Safety Authority.
Regulatory frameworks vary and are documented in legislation and case law from jurisdictions including the United States Congress, the European Parliament, the Supreme Court of Canada, and national statutes such as those enacted in Uruguay and Portugal. International control regimes reference treaties administered by the United Nations Office on Drugs and Crime and policy shifts debated at the Commission on Narcotic Drugs. Licensing, taxation, and market regulation are further detailed in reports from financial institutions such as the International Monetary Fund and national regulators like the Financial Conduct Authority.
Category:Cannabis